| FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 | | OMB APPROVAL | | OMB Number: | 3235-0104 | | Expires: | February 28, 2011 | | Estimated average burden | | hours per response | 0.5 |
|
|
1. Name and Address of Reporting Person*
(Street)| THOUSAND OAKS | CA | 91320-1799 |
| 2. Date of Event Requiring Statement (Month/Day/Year)
06/03/2008 | 3. Issuer Name and Ticker or Trading Symbol
AMGEN INC
[AMGN]
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable) | Director | | 10% Owner | | X | Officer (give title below) | | Other (specify below) | | SVP. WW Compliance |
| 5. If Amendment, Date of Original Filed (Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
| X | Form filed by One Reporting Person | | Form filed by More than One Reporting Person |
|
| Table I - Non-Derivative Securities Beneficially Owned |
|---|
| 1. Title of Security (Instr.
4)
| 2.
Amount of Securities Owned (Instr.
4)
| 3. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
| 4. Nature of Indirect Beneficial Ownership (Instr.
5)
|
|---|
|
Common Stock
|
1,464
|
D
| |
|
Common Stock
|
1,251.229
|
D
| |
|
Common Stock
|
13,372
|
D
| |
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities) |
|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year)
| 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Excercise Price of Derivative Security
| 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)
| 6. Nature of Indirect Beneficial Ownership (Instr. 5)
|
|---|
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
|---|
|
ISO (Right to Buy)
| 12/01/2004 | 12/01/2010 |
Common Stock
|
5,064
|
$
59.23
|
D
| |
|
ISO (Right to Buy)
| 03/15/2008 | 03/15/2011 |
Common Stock
|
3,362
|
$
59.48
|
D
| |
|
ISO (Right to Buy)
| 04/26/2011 | 04/26/2014 |
Common Stock
|
1,598
|
$
62.55
|
D
| |
|
ISO (Right to Buy)
| 04/03/2010 | 04/03/2013 |
Common Stock
|
1,391
|
$
71.88
|
D
| |
|
NQSO (Right to Buy)
| 03/15/2006 | 03/15/2012 |
Common Stock
|
8,571
|
$
58.61
|
D
| |
|
NQSO (Right to Buy)
| 12/01/2004 | 12/01/2010 |
Common Stock
|
9,936
|
$
59.23
|
D
| |
|
NQSO (Right to Buy)
| 03/15/2005 | 03/15/2011 |
Common Stock
|
3,706
|
$
59.48
|
D
| |
|
NQSO (Right to Buy)
| 04/26/2008 | 04/26/2014 |
Common Stock
|
10,902
|
$
62.55
|
D
| |
|
NQSO (Right to Buy)
| 04/03/2007 | 04/03/2013 |
Common Stock
|
6,484
|
$
71.88
|
D
| |
|
NQSO (Right to Buy)
| 04/29/2009 | 04/29/2015 |
Common Stock
|
11,800
|
$
42.13
|
D
| |
| Explanation of Responses: |
|
|
|
|
|
|
|
|
|
|
| /s/ N. Cris Prince, Attorney-in-Fact | 06/12/2008 |
| ** Signature of Reporting Person | Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
| * If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
EX-99.
rrd188532_212673.html
POWER OF ATTORNEY
Know all men by these presents, that the undersigned hereby constitutes and appoints
each of N. Cris Prince, Andrea A. Robinson and Mark A. Schlossberg, signing
singly, the undersigned's true and lawful attorney-in-fact to execute for and on
behalf of the undersigned Forms 3, 4 and 5 in accordance with Section 16(a) of the
Securities Exchange Act of 1934, as amended, and the rules thereunder, as may be
required as a result of the undersigned's position as an officer and/or director of
Amgen Inc. (the "Company").
The undersigned hereby grants to each such attorney-in-fact full power and authority
to execute such Forms 3, 4 and 5 as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the rights
and powers herein granted. The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the request of the undersigned,
are not assuming, nor is the Company assuming, any of the undersigned's
responsibilities to comply with Section 16 of the Securities Exchange Act of 1934,
as amended.
This Power of Attorney shall remain in full force and effect until the undersigned
is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's
holdings of and transactions in securities issued by the Company, unless earlier
revoked by the undersigned in a signed writing delivered to the foregoing
attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executued as of this 6th day of June, 2008.
/s/ Anna S. Richo
--------------------------------
Name: Anna S. Richo